Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue
Orthopedic product sales	$ 16,686	$ 17,830
Other revenue	40	104
Total Revenue	16,726	17,934
Cost of sales	5,913	5,702
Gross Profit	10,813	12,232
Operating Expenses
General and administrative	4,196	3,025
Sales and marketing	6,742	8,349
Research and development	262	414
Depreciation and amortization	159	1,004
Restructuring expenses		733
Non-cash compensation expense	122	364
Total Operating Expenses	11,481	13,889
Loss from Operations	(668)	(1,657)
Other (Expense) Income
Interest expense	(2,018)	(3,545)
Change in warrant derivative liability	(15)	(38)
Other (expense) income	(75)	(13)
Total Other (Expense)	(2,108)	(3,596)
Net Loss Before Provision for Income Taxes	(2,776)	(5,253)
Provision for Income Taxes	(23)
Net Loss	$ (2,799)	$ (5,253)
Net loss per share:
Basic	$ (0.21)	$ (0.70)
Dilutive	$ (0.21)	$ (0.70)
Shares used in the computation:
Basic	13,170,721	7,481,550
Dilutive	13,170,721	7,481,550